Hygea VCT: Investments against COVID-19 ^{UK Investors}

Entity: Hygea VCT
Category: UK Investors
Description: Hygea VCT is an investment company providing investors access to a diversified portfolio of emerging and established MedTech companies. Hygea provides investors with access to a diversified portfolio of emerging and established MedTech companies qualifying for investment by a VCT. The board has a strong track record of investing in this area and has a network of personnel with successful P&L responsibility experience in the MedTech sector, both in the UK and internationally. A key feature of the Hygea investment approach is to ensure that portfolio companies are developed as solutions companies i.e. compete on the basis of value provided to customers (not price) by providing better patient outcomes at lower total cost. The effect of this approach is that portfolio companies tend to be focused around medical devices, drug delivery systems, diagnostics and technology based support services - standalone molecule development companies do not generally qualify as solutions companies.

+ Investing in:

. Omega Diagnostics

Connections

Omega Diagnostics: against COVID-19

Funding Status: N/A

Headquarters: United Kingdom

Founded Date: N/A

Investor Type: N/A

Investment Stage: N/A

Technology: COVID UK Funding&Support

Employee Number: N/A

Number Of Exists: N/A

Industry: COVID UK Non-governmental Bodies

Hygea VCT: Investments against COVID-19 UK Investors

Connections

Hygea VCT: Investments against COVID-19 ^{UK Investors}